Zobrazeno 1 - 10
of 69
pro vyhledávání: '"carrimycin"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3637-3642 (2024)
Xiawan Yang,1– 3,* Yingying Shen,1– 3,* Tonglin Hu,1– 3 Hangchao Li,1– 3 Yun Zhang,1– 3 Yiping Shen,1– 3 Dijiong Wu1– 4 1Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Pr
Externí odkaz:
https://doaj.org/article/cb0eaaf09a6f4e3f946f738e5e395616
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3617-3621 (2024)
Ning Du,1,* Dan You,2,* Dava Tenzing,3 Dongxiang Qu,2 Jun Meng,1,* Yihui Wang,4,* Juan He5,* 1Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese
Externí odkaz:
https://doaj.org/article/fba455c4ae434bc08eb9c1df1d4b72ed
Autor:
Hongying Li, Jianrui Li, Jiayu Li, Hu Li, Xuekai Wang, Jing Jiang, Lei Lei, Han Sun, Mei Tang, Biao Dong, Weiqing He, Shuyi Si, Bin Hong, Yinghong Li, Danqing Song, Zonggen Peng, Yongsheng Che, Jian-Dong Jiang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 6, Pp 2567-2580 (2024)
The pandemic of SARS-CoV-2 worldwide with successive emerging variants urgently calls for small-molecule oral drugs with broad-spectrum antiviral activity. Here, we show that carrimycin, a new macrolide antibiotic in the clinic and an antiviral candi
Externí odkaz:
https://doaj.org/article/0c69026a221e410791cdc5a1b0b2f32b
Autor:
Li, Hongying a, †, Li, Jianrui a, b, †, Li, Jiayu a, Li, Hu a, c, Wang, Xuekai a, Jiang, Jing a, Lei, Lei a, Sun, Han a, Tang, Mei a, Dong, Biao a, c, He, Weiqing c, Si, Shuyi c, Hong, Bin c, Li, Yinghong b, Song, Danqing b, Peng, Zonggen a, b, c, ⁎, Che, Yongsheng c, ⁎, Jiang, Jian-Dong a, b, c, ⁎
Publikováno v:
In Acta Pharmaceutica Sinica B June 2024 14(6):2567-2580
Autor:
Nan, Chuanchuan a, b, d, 1, Zhang, Xiaowu c, 1, Huang, Wei b, 1, Zhu, Biao e, 1, Zhao, Jianghong f, 1, Lu, Song g, 1, Xian, Lewu h, 1, Liu, Kaizhong i, Ma, Gang j, Yang, Wei a, Huang, Mingguang k, Zhou, Dongmin l, Zhang, Ming m, Duan, Yan k, Wu, Guixin n, Jiang, Zhengying n, Zhang, Li °o, He, Xinrong j, Chen, Yuhong p, Xing, Xuezhong q, Wang, Changsong a, b, ⁎, Wang, Donghao c, ⁎⁎, Yu, Kaijiang a, ⁎⁎
Publikováno v:
In Pharmacological Research December 2023 198
Autor:
Chuanchuan Nan, Xiaowu Zhang, Wei Huang, Biao Zhu, Jianghong Zhao, Song Lu, Lewu Xian, Kaizhong Liu, Gang Ma, Wei Yang, Mingguang Huang, Dongmin Zhou, Ming Zhang, Yan Duan, Guixin Wu, Zhengying Jiang, Li Zhang, Xinrong He, Yuhong Chen, Xuezhong Xing, Changsong Wang, Donghao Wang, Kaijiang Yu
Publikováno v:
Pharmacological Research, Vol 198, Iss , Pp 106991- (2023)
Carrimycin is a potential immune-regulating agent for sepsis in patients with tumors. In this study, we investigated its effects on inflammation and immune function in tumor patients with sepsis. In total, 120 participants were randomized to receive
Externí odkaz:
https://doaj.org/article/f2252d7e316045279d46a36620a91458
Autor:
LaYow C. Yu, Danielle D. Dang, Sophie Zhuang, Shuran Chen, Zhengping Zhuang, Jared S. Rosenblum
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 1, Iss 2, Pp 111-115 (2023)
Carrimycin is a synthetic macrolide antibiotic that has been shown to have anti-cancer activity; however, its exact mechanism of action and molecular target were previously unknown. It was recently elucidated that Isovalerylspiramycin I (ISP I), the
Externí odkaz:
https://doaj.org/article/9651752da30841468a61fc6288919109
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 2365-2369 (2023)
Wenjun Zhu,* Yaping Tian,* Lin Xiang, Linna Cao, Lirong He Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of China*These authors contribu
Externí odkaz:
https://doaj.org/article/184cb418aa1c40edbd3ba66ce5eb15ce
Autor:
Yu, LaYow C., Dang, Danielle D., Zhuang, Sophie, Chen, Shuran, Zhuang, Zhengping ∗∗, Rosenblum, Jared S. ∗
Publikováno v:
In Cancer Pathogenesis and Therapy April 2023 1(2):111-115
Autor:
Jing Cui, Jingcheng Zhou, Weiqing He, Juan Ye, Timothy Westlake, Rogelio Medina, Herui Wang, Bhushan L. Thakur, Juanjuan Liu, Mingyu Xia, Zhonggui He, Fred E. Indig, Aiguo Li, Yan Li, Robert J. Weil, Mirit I. Aladjem, Laiping Zhong, Mark R. Gilbert, Zhengping Zhuang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-15 (2022)
Abstract Background Compared to normal cells, cancer cells exhibit a higher level of oxidative stress, which primes key cellular and metabolic pathways and thereby increases their resilience under oxidative stress. This higher level of oxidative stre
Externí odkaz:
https://doaj.org/article/445271d602864e3ab3bd004faac35132